Pei Ting Tan

Pei Ting Tan

Auto-generated profile, based on publicly available information

Pei Ting Tan

Health Services Research Changi General Hospital Singapore City Singapore

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2021 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
CCChang Yin Chionh
Chang Yin Chionh
CPCheng Boon Poh
Cheng Boon Poh
DRDebajyoti M. Roy
Debajyoti M. Roy
SKSreekanth Koduri
Sreekanth Koduri
BCBing Lun Chow
Bing Lun Chow
TarChoon AwTarChoon Aw
TarChoon Aw

15 January 2022 in Journal of Arrhythmia
Verified
Journal Article
Open access
PDF file
XPXuanming Pung
Xuanming Pung
DHDaniel Zhihao Hong
Daniel Zhihao Hong
THTzyy Yeou Ho
Tzyy Yeou Ho
XSXiayan Shen
Xiayan Shen
PTPei Ting Tan
Pei Ting Tan
VTVern Hsen Tan
Vern Hsen Tan
This meta-analysis aims to evaluate the performance of atrial sensing dipole in single lead implantable cardioverter defibrillator (VDD-ICD) recipients in particular diagnosing new-onset atrial high-rate episodes (AHREs) defined as rate threshold of 200 beats per minute, or subclinical atrial fibrillation (SCAF) defined as device-detected AF without symptoms. We comprehensively searched PubMed, Embase, and ClinicalTrials.gov. Studies comparing contemporary single- and dual-chamber ICD (VVI-/DDD-ICD) versus VDD-ICD were included. Restricted maximum likelihood method for random effect model and Mantel-Haenszel method for fixed effect model were used to estimate the effect size of new-onset AHREs, or SCAF detection in each group. Three prospective studies were identified and total of 991 participants were included. There were 330 (33.3%) in VDD-ICD and 661 (66.7%) in VVI-/DDD-ICD. Most (78%) participants were men. Median follow-up was from 365 days to 847 days. VDD-ICD has a higher likelihood of detecting AHREs or SCAF as compared to VVI-/DDD-ICD [(OR random effect : 2.6; 95% CI: 1.2, 5.8; p = .018); I-squared = 67.8%, p = .019]. This difference was more apparently seen in the comparison between VDD-ICD and VVI-ICD [(OR random effect: 3.8; 95% CI: 2.1, 6.6, p < .001), I-squared = 0.0%, p = .518]. The result is same as fixed effect. Rate of AHREs detection observed in VDD-ICD was not statistically different when compared to the only group with DDD-ICD from SENSE trial. In conclusion, this meta-analysis reveals that the use of floating atrial sensing dipole in VDD-ICD increases the detection of new-onset AHREs or SCAF when compared to VVI-ICD, with similar atrial sensing performance to DDD-ICD.